Surgery for Pancreatic Metastases from Kidney Cancer
Author Information
Author(s): Matei Emil, Ciurea Silviu, Herlea Vlad, Dumitrascu Traian, Vasilescu Catalin
Primary Institution: Fundeni Clinical Institute, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania
Hypothesis
The study aims to explore the role of surgery in pancreatic metastases from renal cell carcinoma, particularly regarding indications, types of pancreatectomies, and outcomes.
Conclusion
Pancreatectomies for pancreatic metastases from renal cell carcinoma can lead to long-term survival when complete resection is possible, with acceptable complication rates.
Supporting Evidence
- 20 patients underwent surgery for pancreatic metastases from renal cell carcinoma.
- 90% of the cases were metachronous, with a median interval of 104 months from nephrectomy to metastasis.
- Patients with negative resection margins had a median survival of 128 months.
Takeaway
Doctors can sometimes remove cancer from the pancreas that started in the kidneys, and this can help patients live longer.
Methodology
The study retrospectively assessed data from patients who underwent surgery for pancreatic metastases from renal cell carcinoma between January 2002 and December 2023.
Potential Biases
Potential biases may arise from the retrospective nature of the study and the specific patient population at a single center.
Limitations
The study's retrospective design and small sample size may limit the generalizability of the findings.
Participant Demographics
The cohort included 20 patients, with a median age of 64 years, consisting of 6 females (30%) and 14 males (70%).
Statistical Information
P-Value
0.019
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website